David Hilbert

David Hilbert is a Principal Scientist at Merck, specializing in infectious disease research. Previously, they held positions at Genesis Biotechnology Group and Columbia University, where they contributed to various aspects of antimicrobial resistance and drug discovery. With a Ph.D. in Microbiology and Immunology from Temple University and a B.S. in Biology from The College of New Jersey, David possesses extensive expertise in laboratory science, clinical research, and assay development. They are recognized for their management experience in early-stage drug discovery and the innovative development of diagnostic tests and disease models.